MedPageToday -- Dietary supplementation with the omega-3 fat docosahexaenoic acid (DHA) had no apparent benefit in slowing cognitive decline among patients with mild-to-moderate Alzheimer’s disease, according to a large randomized trial.
MedPageToday -- Dietary supplementation with the omega-3 fat docosahexaenoic acid (DHA) had no apparent benefit in slowing cognitive decline among patients with mild-to-moderate Alzheimer’s disease, according to a large randomized trial.
